Identifying Medicare patients with high blood pressure will be a little easier now that the federal government has expanded coverage of a device that continuously tracks blood pressure over a 24-hour period.
In a July 2 decision, the Centers for Medicare and Medicaid Services completed its national coverage policy for ambulatory blood pressure monitoring (ABPM), a non-invasive diagnostic test that lets doctors check patients’ blood pressure as they go through their normal day.
Readings taken while patients sit nervously in doctors’ offices can often provide inaccurate results leading to false diagnoses of hypertension known as “white coat hypertension.”
The new ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.